Comparative Experimental Study of the Serum Prostate Specific Antigen and Prostatic Acid Phosphatase in Serially Transplantable Human Prostatic Carcinoma Lines in Nude Mice-Reference-Cited by-同舟云学术

Comparative Experimental Study of the Serum Prostate Specific Antigen and Prostatic Acid Phosphatase in Serially Transplantable Human Prostatic Carcinoma Lines in Nude Mice

Published:1988-11 Issue:5 Part 1 Volume:140 Page:1032-1038
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Csapo Zoltan¹,Brand Karl¹,Walther Reimund¹,Fokas Konstantinos¹

Affiliation:

1. From the Department of Urology and Institute of Biochemistry, Medical Faculty, University of Erlangen-Nurnberg, Federal Republic of Germany

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference19 articles.

1. Human prostatic adenocarcinoma: some characteristics of a serially transplantable line in nude mice (PC-82);Höhn;Prostate,1980

2. Human prostatic adenocarcinoma: comparative experimental treatment of the tumor line PC-82 in nude mice;Höhn;Prostate,1982

3. Prostatic adenocarcinoma PC-EW, a new human tumor line transplantable in nude mice;Höhn;Prostate,1984

4. Purification of a human prostate specific antigen;Wang;Invest. Urol.,1979

5. Detection of prostate cancer by solid phase radioimmunoassay of serum prostatic acid phosphatase;Foti;N. Engl. J. Med.,1977

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mouse Models in Prostate Cancer Translational Research: From Xenograft to PDX;BioMed Research International;2016

2. A population study of fasting time and serum prostate-specific antigen (PSA) level;Asian Journal of Andrology;2014

3. Human prostate cancer heterotransplants: a review on this experimental model;Asian Journal of Andrology;2010-04-05

4. Serially heterotransplanted human prostate tumours as an experimental model;Journal of Cellular and Molecular Medicine;2009-10-29

5. Pathologic characterization of prostate cancers with a very low serum prostate specific antigen (0–2 ng/mL) incidental to cystoprostatectomy: is PSA a useful indicator of clinical significance?;Urologic Oncology: Seminars and Original Investigations;2004-01